Nuriplan Co., Ltd

As of March 31, 2026, Nuriplan Co., Ltd carries a market capitalization of 30.59B, placing it among publicly traded companies globally. Its enterprise value stands at 77.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Nuriplan Co., Ltd has 15.07M shares outstanding.

As of March 31, 2026, Nuriplan Co., Ltd trades at a trailing price-to-earnings ratio of 20.51. The price-to-sales ratio is 0.23, and the price-to-book ratio stands at 0.72.

As of March 31, 2026, Nuriplan Co., Ltd trades at an EV/EBITDA multiple of 7.85 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 12.71 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 77.36B versus a market cap of 30.59B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Nuriplan Co., Ltd maintains a current ratio of 0.61, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Nuriplan Co., Ltd posted a return on equity (ROE) of 3.40, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 0.98, measuring how efficiently the asset base is converted into earnings. The company generates approximately 2.48B in revenue per employee across its workforce of 49.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.42 indicates how many times Nuriplan Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Nuriplan Co., Ltd recorded an income tax benefit of -2.42B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 434.33M, leaving 1.37B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Nuriplan Co., Ltd's stock has declined approximately 37.84% over the past 52 weeks. The 50-day moving average sits at 1,796.56, while the 200-day moving average is 2,041.05.

Over the twelve months ended March 31, 2026, Nuriplan Co., Ltd generated 121.41B in revenue and converted that into 1.37B in net income, yielding earnings per share of 188.74. EBITDA reached 9.86B, while operating income came in at 6.11B.

As of March 31, 2026, Nuriplan Co., Ltd holds 6.45B in cash and equivalents against 46.07B in total debt, resulting in a net debt position of 41.21B. Total book value stands at 42.37B, with working capital of -28.96B providing operational flexibility.

Nuriplan Co., Ltd produced 5.21B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -2.89B in capital expenditures, free cash flow totaled 2.32B - equivalent to 167.57 per share.

Over the twelve months ended March 31, 2026, Nuriplan Co., Ltd posted a gross margin of 21.90, reflecting its pricing power and cost economics. The operating margin of 5.04 and net profit margin of 1.13 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 7.55, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 14.48, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Nuriplan Co., Ltd shareholders.

Nuriplan Co., Ltd's most recent stock split took place on September 26, 2023 with a 986:1167 split ratio.

As of March 31, 2026, Nuriplan Co., Ltd has an Altman Z-Score of 0.97, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.